Long Intergenic Noncoding RNAs Mediate the Human Chondrocyte Inflammatory Response and Are Differentially Expressed in Osteoarthritis Cartilage

Arthritis and Rheumatology

Volumn 68, Issue 4, 2016, Pages 845-856

  Pearson, Mark J ^a   Philp, Ashleigh M ^a   Heward, James A ^b   Roux, Benoit T ^b   Walsh, David A ^c   Davis, Edward T ^d   Lindsay, Mark A ^b   Jones, Simon W ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF BATH   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; COMPLEMENTARY RNA; INTERLEUKIN 1BETA; LONG UNTRANSLATED RNA; CYTOKINE; INTERLEUKIN 1;

AGED; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMUR NECK FRACTURE; GENE EXPRESSION; GENE SILENCING; HIP OSTEOARTHRITIS; HIP PROSTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; KNEE OSTEOARTHRITIS; KNEE PROSTHESIS; OSTEOARTHRITIS; PRIORITY JOURNAL; PSEUDOGENE; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; CASE CONTROL STUDY; CHONDROCYTE; FEMALE; FEMORAL NECK FRACTURES; GENE EXPRESSION PROFILING; HIP REPLACEMENT; IMMUNOLOGY; IN VITRO STUDY; INFLAMMATION; KNEE REPLACEMENT; MALE; METABOLISM; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; CARTILAGE, ARTICULAR; CASE-CONTROL STUDIES; CHONDROCYTES; CYTOKINES; FEMALE; FEMORAL NECK FRACTURES; GENE EXPRESSION PROFILING; HUMANS; IN VITRO TECHNIQUES; INFLAMMATION; INTERLEUKIN-1; MALE; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING;

EID: 84962129131     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39520     Document Type: Article

References (47)

1. Pereira D, Severo M, Santos RA, Barros H, Branco J, Lucas R, et al., Knee and hip radiographic osteoarthritis features: differences on pain, function and quality of life. Clin Rheumatol 2015. E-pub ahead of print.
2. Felson DT., Developments in the clinical understanding of osteoarthritis. Arthritis Res Ther 2009; 11: 203.
3. Peat G, Thomas E, Handy J, Wood L, Dziedzic K, Myers H, et al., The Knee Clinical Assessment Study-CAS(K): a prospective study of knee pain and knee osteoarthritis in the general population. BMC Musculoskelet Disord 2004; 5: 4.
4. Tonge DP, Pearson MJ, Jones SW., The hallmarks of osteoarthritis and the potential to develop personalised disease-modifying pharmacological therapeutics. Osteoarthritis Cartilage 2014; 22: 609-21.
5. Oehler S, Neureiter D, Meyer-Scholten C, Aigner T., Subtyping of osteoarthritic synoviopathy. Clin Exp Rheumatol 2002; 20: 633-40.
6. Fernandez-Madrid F, Karvonen RL, Teitge RA, Miller PR, An T, Negendank WG., Synovial thickening detected by MR imaging in osteoarthritis of the knee confirmed by biopsy as synovitis. Magn Reson Imaging 1995; 13: 177-83.
7. Rhodes LA, Conaghan PG, Radjenovic A, Grainger AJ, Emery P, McGonagle D., Further evidence that a cartilage-pannus junction synovitis predilection is not a specific feature of rheumatoid arthritis. Ann Rheum Dis 2005; 64: 1347-9.
8. Myers SL, Brandt KD, Ehlich JW, Braunstein EM, Shelbourne KD, Heck DA, et al., Synovial inflammation in patients with early osteoarthritis of the knee. J Rheumatol 1990; 17: 1662-9.
9. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H., Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011; 7: 33-42.
10. Brown KK, Heitmeyer SA, Hookfin EB, Hsieh L, Buchalova M, Taiwo YO, et al., P38 MAP kinase inhibitors as potential therapeutics for the treatment of joint degeneration and pain associated with osteoarthritis. J Inflamm (Lond) 2008; 5: 22.
11. Lindsay MA., microRNAs and the immune response. Trends Immunol 2008; 29: 343-51.
12. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D., Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010; 10: 111-22.
13. Jones SW, Watkins G, Le Good N, Roberts S, Murphy CL, Brockbank SM, et al., The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-α and MMP13. Osteoarthritis Cartilage 2009; 17: 464-72.
14. Guttman M, Amit I, Garber M, French C, Lin MF, Feldser D, et al., Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 2009; 458: 223-7.
15. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, Rivea MD, et al., Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 2009; 106: 11667-72.
16. Guttman M, Rinn JL., Modular regulatory principles of large non-coding RNAs. Nature 2012; 482: 339-46.
17. Ponting CP, Belgard TG., Transcribed dark matter: meaning or myth? Hum Mol Genet 2010; 19: R162-8.
18. Clark MB, Mattick JS., Long noncoding RNAs in cell biology. Semin Cell Dev Biol 2011; 22: 366-76.
19. Wang KC, Chang HY., Molecular mechanisms of long noncoding RNAs. Mol Cell 2011; 43: 904-14.
20. Heward JA, Lindsay MA., Long non-coding RNAs in the regulation of the immune response. Trends Immunol 2014; 35: 408-19.
21. IIott NE, Heward JA, Roux B, Tsitsiou E, Fenwick PS, Lenzi L, et al., Long non-coding RNAs and enhancer RNAs regulate the lipopolysaccharide-induced inflammatory response in human monocytes [published erratum appears in Nat Commun 2015;6:6814]. Nat Commun 2014; 5: 3979.
22. Fu M, Huang G, Zhang Z, Liu J, Zhang Z, Huang Z, et al., Expression profile of long noncoding RNAs in cartilage from knee osteoarthritis patients. Osteoarthritis Cartilage 2015; 23: 423-32.
23. Krawczyk M, Emerson BM., p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-κB complexes. Elife 2014; 3: e01776.
24. Siegle I, Klein T, Backman JT, Saal JG, Nusing RM, Fritz P., Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum 1998; 41: 122-9.
25. Pelletier JP, Boileau C, Brunet J, Boily M, Lajeunesse D, Reboul P, et al., The inhibition of subchondral bone resorption in the early phase of experimental dog osteoarthritis by licofelone is associated with a reduction in the synthesis of MMP-13 and cathepsin K. Bone 2004; 34: 527-38.
26. Raynauld JP, Martel-Pelletier J, Bias P, Laufer S, Haraoui B, Choquette D, et al., Protective effects of licofelone, a 5-lipoxygenase and cyclo-oxygenase inhibitor, versus naproxen on cartilage loss in knee osteoarthritis: a first multicentre clinical trial using quantitative MRI. Ann Rheum Dis 2009; 68: 938-47.
27. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957; 16: 494-501.
28. Walsh DA, Yousef A, McWilliams DF, Hill R, Hargin E, Wilson D., Evaluation of a Photographic Chondropathy Score (PCS) for pathological samples in a study of inflammation in tibiofemoral osteoarthritis. Osteoarthritis Cartilage 2009; 17: 304-12.
29. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A, et al., Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 2011; 25: 1915-27.
30. Goldring MB, Birkhead JR, Suen LF, Yamin R, Mizuno S, Glowacki J, et al., Interleukin-1β-modulated gene expression in immortalized human chondrocytes. J Clin Invest 1994; 94: 2307-16.
31. Andersson R, Gebhard C, Miguel-Escalada I, Hoof I, Bornholdt J, Boyd M, et al., An atlas of active enhancers across human cell types and tissues. Nature 2014; 507: 455-61.
32. Podolin PL, Callahan JF, Bolognese BJ, Li YH, Carlson K, Davis TG, et al., Attenuation of murine collagen-induced arthritis by a novel, potent, selective small molecule inhibitor of IκB kinase 2, TPCA-1 (2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigen-induced T cell proliferation. J Pharmacol Exp Ther 2005; 312: 373-81.
33. Tagoug I, Sauty De Chalon A, Dumontet C., Inhibition of IGF-1 signalling enhances the apoptotic effect of AS602868, an IKK2 inhibitor, in multiple myeloma cell lines. PLoS One 2011; 6: e22641.
34. Nan J, Du Y, Chen X, Bai Q, Wang Y, Zhang X, et al., TPCA-1 is a direct dual inhibitor of STAT3 and NF-κB and regresses mutant EGFR-associated human non-small cell lung cancers. Mol Cancer Ther 2014; 13: 617-29.
35. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, et al., GENCODE: the reference human genome annotation for the ENCODE Project. Genome Res 2012; 22: 1760-74.
36. Hu G, Tang Q, Sharma S, Yu F, Escobar TM, Muljo SA, et al., Expression and regulation of intergenic long noncoding RNAs during T cell development and differentiation. Nat Immunol 2013; 14: 1190-8.
37. Loughlin J, Reynard LN., Osteoarthritis: epigenetics of articular cartilage in knee and hip OA. Nat Rev Rheumatol 2015; 11: 6-7.
38. Xu Y, Barter MJ, Swan DC, Rankin KS, Rowan AD, Santibanez-Koref M, et al., Identification of the pathogenic pathways in osteoarthritic hip cartilage: commonality and discord between hip and knee OA. Osteoarthritis Cartilage 2012; 20: 1029-38.
39. Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B., Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005; 64: 1263-7.
40. Buckley CD, Gilroy DW, Serhan CN, Stockinger B, Tak PP., The resolution of inflammation. Nat Rev Immunol 2013; 13: 59-66.
41. 2 brings about acute inflammatory resolution in rat pleurisy by inducing neutrophil and macrophage apoptosis. FASEB J 2003; 17: 2269-71.
42. 4 production. J Immunol 2010; 184: 6418-26.
43. Hartgring SA, van Roon JA, Wenting-van Wijk M, Jacobs KM, Jahangier ZN, Willis CR, et al., Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis. Arthritis Rheum 2009; 60: 2595-605.
44. Van Roon JA, Glaudemans KA, Bijlsma JW, Lafeber FP., Interleukin 7 stimulates tumour necrosis factor α and Th1 cytokine production in joints of patients with rheumatoid arthritis. Ann Rheum Dis 2003; 62: 113-9.
45. Long D, Blake S, Song XY, Lark M, Loeser RF., Human articular chondrocytes produce IL-7 and respond to IL-7 with increased production of matrix metalloproteinase-13. Arthritis Res Ther 2008; 10: R23.
46. Iwamura C, Kimura MY, Shinoda K, Endo Y, Hasegawa A, Yamashita M, et al., Schnurri-2 regulates Th2-dependent airway inflammation and airway hyperresponsiveness. Int Immunol 2007; 19: 755-62.
47. Imamura K, Maeda S, Kawamura I, Matsuyama K, Shinohara N, Yahiro Y, et al., Human immunodeficiency virus type 1 enhancer-binding protein 3 is essential for the expression of asparagine-linked glycosylation 2 in the regulation of osteoblast and chondrocyte differentiation. J Biol Chem 2014; 289: 9865-79.